PTSD Help - a Randomized Controlled Trial of a PTSD Mobile Health App
Feasibility and Potential Efficacy of the PTSD Help App in a Danish PTSD Population: A Randomized Controlled Feasibility Trial
1 other identifier
interventional
64
1 country
1
Brief Summary
Due to an increase in PTSD patients seeking treatment in the Danish mental health sector and the addition of Complex PTSD to the ICD-11, there is a need to increase the effectiveness of existing treatments for PTSD. mHealth interventions have been shown to be effective in reducing PTSD symptoms with small to moderate effect sizes. Therefore, the implementation of a mHealth intervention designed for psychiatric PTSD patients as a supplement to therapy may increase treatment outcome. As no studies to date has explored the effects of mHealth interventions in the Danish mental health sector the feasibility and effect of this type of intervention needs testing. The study's primary hypothesis is that PTSD patients in a Danish psychiatric outpatient setting will want to use a mHealth application as a supplement to care as usual (CAU). The secondary hypothesis is that PTSD patients will benefit from using a mHealth application as a supplement to CAU The study is an investigator-initiated randomized controlled feasibility trial investigating PTSD help combined with CAU compared to CAU for adults with PTSD. Eighty patients will be recruited and receive either the mHealth intervention combined with CAU or CAU alone. Primary outcome is the ratio of eligible patients that agree to participate in the study and the level of user compliance. Secondary outcome data consists of exploratory data on PTSD help on PTSD symptom severity, level of psychological distress, sleep quality, dissociation symptoms, therapy readiness, quality of life, disability levels, recovery and rumination. This study may help increase the investigator's knowledge of possible benefits of, as well as potential barriers to, the implementation of mHealth tools. It may also provide a cost-efficient means to increase therapy outcomes and decrease the duration of suffering for PTSD patients in the Danish psychiatric sector.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2019
CompletedFirst Posted
Study publicly available on registry
March 5, 2019
CompletedStudy Start
First participant enrolled
March 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedSeptember 3, 2020
September 1, 2020
1.6 years
February 27, 2019
September 1, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Randomization ratio
Ratio of eligible patients that can be randomized
40 weeks
compliance with intervention
Fraction of patients that used the intervention continously until the end of the study
34 weeks
Secondary Outcomes (9)
PTSD Checklist for DSM-V
1 month
Dissociative Symptoms Scale
1 week
the Symptom Checklist-10
2 weeks
WHO-5
2 weeks
INSPIRE
2 weeks
- +4 more secondary outcomes
Study Arms (2)
Experimental group
EXPERIMENTALPTSD Help intervention combined with care as usual.
Control group
NO INTERVENTIONCare as usual.
Interventions
Experimental group will receive the app, PTSD Help.
Eligibility Criteria
You may qualify if:
- Must be at least 18 years old.
- Fulfil the DSM-5 PTSD diagnosis criteria.
- Be referred to PTSD care package treatment (Danske regioner, pakkeforløb for PTSD, 2017)
- Have access to a smartphone with iOS (version 10 or higher) or Android (version 5.0.1. or higher)
- Provide informed consent.
You may not qualify if:
- Suicidal risk
- Ongoing episode of bipolar disease or psychotic disorder
- Current abuse of alcohol or drugs
- Inability to understand and/or read Danish
- Concurrent psychiatric or psychological treatment of PTSD outside of MHS-CRD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Psykoterapeutisk Center Stolpegaard
Copenhagen, Gentofte, 2820, Denmark
Related Publications (1)
Scharff FB, Lau ME, Riisager LHG, Moller SB, Salimi ML, Gondan M, Folke S. The PTSD help app in a Danish PTSD population: research protocol of a randomized controlled feasibility trial. Pilot Feasibility Stud. 2020 Jun 30;6:92. doi: 10.1186/s40814-020-00633-x. eCollection 2020.
PMID: 32617173DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Stine B. Moeller, Ph.D.
Head of Research Unit
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project manager
Study Record Dates
First Submitted
February 27, 2019
First Posted
March 5, 2019
Study Start
March 14, 2019
Primary Completion
November 1, 2020
Study Completion
July 31, 2021
Last Updated
September 3, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share